Related Experiment Videos
IgA autoimmune disorders: development of a passive transfer mouse model
John J Zone1, C Anthony Egan, Ted B Taylor
1Veterans Administration Medical Center, Salt Lake City, Utah, USA. Zone@derm.med.utah.edu
The Journal of Investigative Dermatology. Symposium Proceedings
|February 12, 2004
Summary
Researchers developed an animal model for IgA dermatoses. This model uses passive transfer of IgA antibodies to induce skin inflammation, aiding the study of diseases like linear IgA bullous dermatosis.
Area of Science:
- Immunodermatology
- Animal models of human disease
Background:
- Immunoglobulin A (IgA) is implicated in various skin diseases, including dermatitis herpetiformis and linear IgA bullous dermatosis.
- Neutrophilic infiltration at IgA deposition sites suggests IgA's role in inflammation, possibly via neutrophil chemotaxis.
Purpose of the Study:
- To establish a viable animal model for studying the pathogenesis of IgA-mediated dermatoses.
- To investigate the mechanism of IgA-induced inflammation in skin diseases.
Main Methods:
- Development of a SCID mouse model engrafted with human skin.
- Passive transfer of mouse IgA monoclonal antibodies targeting a linear IgA bullous dermatosis antigen into these mice.
Main Results:
- Neutrophil infiltration and basement membrane vesiculation were observed in 4 out of 12 mice.
- Successful induction of key pathological features of IgA dermatoses in the animal model.
Conclusions:
- Passive transfer of specific IgA antibodies can successfully model IgA dermatoses.
- This animal model provides a platform for elucidating IgA-mediated inflammation mechanisms and testing therapies.